Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Gentian Diagnostics ASA ( (DE:6FK) ) has shared an announcement.
Gentian Diagnostics ASA’s CEO, Matti Heinonen, is set to present at the Pareto Securities Healthcare conference, highlighting the company’s ongoing engagement with industry stakeholders. This presentation signifies Gentian’s proactive approach in maintaining its presence and influence within the healthcare diagnostics sector.
More about Gentian Diagnostics ASA
Gentian Diagnostics ASA operates in the healthcare industry, specializing in the development and production of diagnostic tests. The company focuses on providing innovative solutions for clinical diagnostics, catering to a global market.
Average Trading Volume: 7,694
Current Market Cap: NOK876M
See more data about 6FK stock on TipRanks’ Stock Analysis page.